title: Molecular modeling on pyrimidine-urea inhibitors of TNF-α production: an integrated approach using a combination of molecular docking, classification techniques, and 3D-QSAR CoMSIA.
abstract: Molecular docking, classification techniques, and 3D-QSAR CoMSIA were combined in a multistep framework with the ultimate goal of identifying potent pyrimidine-urea inhibitors of TNF-α production. Using the crystal structure of p38α, all the compounds were docked into the enzyme active site. The docking pose of each compound was subsequently used in a receptor-based alignment for the generation of the CoMSIA fields. "Active" and "inactive" compounds were used to build a Random Tree classification model using the docking score and the CoMSIA fields as input parameters. Domain of applicability indicated the compounds for which activity estimations can be accepted with confidence. For the active compounds, a 3D-QSAR CoMSIA model was subsequently built to accurately estimate the IC(50) values. This novel multistep framework gives insight into the structural characteristics that affect the binding and the inhibitory activity of these analogues on p38α MAP kinase, and it can be extended to other classes of small-molecule inhibitors. In addition, the simplicity of the proposed approach provides expansion to its applicability such as in virtual screening procedures.
authors.affiliation: Department of Chemoinformatics, NovaMechanics, Ltd., Nicosia, Cyprus.
authors.forename: Varnavas D
authors.initials: VD
authors.lastname: Mouchlis
authors.forename: Georgia
authors.initials: G
authors.lastname: Melagraki
authors.forename: Thomas
authors.initials: T
authors.lastname: Mavromoustakos
authors.forename: George
authors.initials: G
authors.lastname: Kollias
authors.forename: Antreas
authors.initials: A
authors.lastname: Afantitis
mesh_terms: D000465:Algorithms; D020134:Catalytic Domain; D002460:Cell Line; D016002:Discriminant Analysis; D006801:Humans; D020128:Inhibitory Concentration 50; D048308:Mitogen-Activated Protein Kinase 14 / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D008958:Models, Molecular; D011487:Protein Conformation; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D011743:Pyrimidines / Q000737:chemistry*; D021281:Quantitative Structure-Activity Relationship; D015203:Reproducibility of Results; D018511:Systems Integration; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*; D014508:Urea / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology*
chemical_list: D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D014409:Tumor Necrosis Factor-alpha; D014508:Urea; D048308:Mitogen-Activated Protein Kinase 14; C030986:pyrimidine